There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

Young patient's journey with thyroid disorder, radioactive iodine treatment, and importance of iodine in the body.

"Based on the FDA's requirement for an additional clinical trial demonstrating the efficacy of reproxalap in treating the symptoms of dry eye disease, and per agreement with the FDA, the NDA ...

About Reproxalap Reproxalap is an investigational new drug candidate in development for the treatment of dry eye disease and allergic conjunctivitis, two of the largest markets in ophthalmology.

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study presented at ENDO 2025, the Endocrine Society's annual meeting in ...

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

Although the relationship between Hcy and thyroid diseases is not complete, changes in Hcy level are still considered by many scholars to be the cause or consequence of thyroid diseases. This article ...

After a while, she says her left eye traveled up into her head, and she could no longer see it, so she started wearing an eye patch. And after several doctor's visits, she was diagnosed with Graves' ...